IMSH Delivers Sessions - Scroll down to "ADD to your Briefcase"
SSH Serious Games and Virtual Environments Section
CE Hours: 1.00 Session Type: Prerecorded Educational Courses Cost: $0.00
Learning Objective 1:
Discuss the pedagogical foundations and research that support the use of serious games and virtual simulations in healthcare education
Learning Objective 2:
Identify metrics to select a serious game or virtual simulation that can be leveraged to address a selected learning challenge in their institutional setting
Learning Objective 3:
Create a proposal that identifies a learning challenge and select a serious game or virtual simulation to address this challenge
Course Overview:
Virtual simulations and game-based activities are increasingly popular in healthcare education. Such activities can help to engage learners, challenge them to grow, and provide them with focused feedback. In this active learning workshop is designed for those new to the use of virtual simulations, participants will learn and apply key pedagogical principles and expert approaches to select and evaluate virtual simulations for their learners.
Co-Presenter: Rachel Umoren, MD, MS, University of Washington About the co-presenter: Dr. Rachel Umoren is an Associate Professor of Pediatrics at the University of Washington. Her interests are in interprofessional education, virtual simulation and health services research. Her current research investigates the best practices and outcomes of educating health professionals through virtual reality simulations.
Disclosure: No financial relationships with ineligible companies.
Co-Presenter: Sage Wexner, AAS, BS, MD, Kern Medical About the co-presenter: Emergency Medicine physician and sim director
Disclosure: No financial relationships with ineligible companies.
Co-Presenter: Dr. Nicholas Slamon, MD, Nemours About the co-presenter: Nicholas Slamon MD FAAP is the fellowship program director of the Nemours/duPont Hospital for Children Pediatric Critical Care Medicine fellowship, and the former medical director for Telehealth, Nemours CareConnect at the duPont Hospital for Children. Prior to his time at duPont, Dr. Slamon was an attending physician and the fellowship program director at the University of Florida/Shand’s Hospital in Gainesville Florida. Dr. Slamon is a member of the American Academy of Pediatrics and both its Delaware chapter and the section on Critical Care medicine, a member of the Society of Critical Care Medicine and its Section on Pediatric Critical Care Medicine, Pediatric Section Fellowship Directors Committee, Tele-ICU committee, MCCKAP (Multidisciplinary Critical Care Knowledge Assessment Program) Committee and the American Telemedicine Association.
Dr. Slamon’s research interests include telemedicine and its application to critical care transport, rapid response applications of telemedicine, telemedicine use in pediatric subspecialty medicine, technology and its application to pediatric medicine, wearable technology as it pertains to the biometric parameters of pediatric critical care physicians in stressful situations both simulated and real life, Post intensive care unit syndrome in pediatrics, viral infections in pediatric intensive care patients, hypercoagulability in pediatric critical care, pediatric safety specifically related to button battery ingestion, and infant botulism.
He has written multiple book chapters and peer reviewed journal articles related to his listed research interests above. He has been an invited lecturer, presenter and interviewed over 40 times for his expertise in telemedicine, button battery ingestion and infant botulism. He has served as an expert reviewer for the Pediatric Emergency Care Journal, Pediatric Critical Care Medicine Journal, Pediatrics, the official journal of the American Academy of Pediatrics and is a board review question author for the American Board of Pediatrics and the Multidisciplinary Critical Care Knowledge Assessment Program for the Society of Critical Care Medicine. He is currently the primary investigator or collaborating researcher on 15 different IRB approved studies at Nemours as well national collaborative work with the RESTORE study (Randomized evaluation of sedation titration for respiratory failure), Half-Pint study for blood sugar management in children in the PICU, SPIN (subspecialty Pediatrics Investigators Network), The IDeA States Pediatric Clinical Trials Network (ISPCTN) and collaborative studies in wearable monitoring and telemedicine with the Children’s Hospital of Philadelphia and Cooper University Hospital.
Dr. Slamon is a well-respected clinician and national leader in telemedicine who is sought after for opinion and consultation by other health systems who are just starting to grow their telemedicine practice. His experience encompasses evaluation of new technology, design of IRB approved research studies in telehealth, legal considerations of cross state licensure and credentialing rules, telehealth billing and reimbursement as well as marketing strategies associated with growth of a telemedicine program. His general philosophy is that telemedicine should be a vehicle to increase patient access to the care they need but might not otherwise be able to obtain. That care should measure up to the same standard as any office visit in person with their physician. The care rendered by telemedicine technology should be appropriate to the condition presented, ethical, and supported by evidence based studies published in the literature. It is his hope that as technology and the practice of telemedicine continues to advance it will become considered just medicine.
Disclosure: No financial relationships with ineligible companies.